78
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Distribution and resistance of pathogens in liver transplant recipients with Acinetobacter baumannii infection

, , , &
Pages 501-505 | Published online: 26 Mar 2015

References

  • KimSIBacterial infection after liver transplantationWorld J Gastroenterol2014206211622024876741
  • DummerJSSinghNInfections in solid organ transplant recipientsMandellGLBennettJEDolinRMandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases7th edPhiladelphia, PA, USAChurchill Livingstone2010
  • FishmanJAInfection in solid-organ transplant recipientsN Engl J Med20073572601261418094380
  • KusneSDummerJSSinghNInfections after liver transplantation. An analysis of 101 consecutive casesMedicine (Baltimore)1988671321433280944
  • SoongRSChanKMChouHSThe risk factors for early infection in adult living donor liver transplantation recipientsTransplant Proc20124478478622483495
  • ShiSHKongHSXuJMultidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipientsTransplant Infect Dis200911405412
  • FalagasMESnydmanDRGriffithJExposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipientsClin Infect Dis1996234684748879766
  • SgangaGSpanuTBiancoGBacterial bloodstream infections in liver transplantation: etiologic agents and antimicrobial susceptibility profilesTransplant Proc2012441973197622974885
  • WanQQYeQFMingYZThe risk factors for mortality in deceased donor liver transplant recipients with bloodstream infectionsTransplant Proc20134530530723375319
  • KimSKimYJJunYHEpidemiology and risk factors for bacteremia in 144 consecutive living-donor liver transplant recipientsYonsei Med J20095011212119259357
  • IidaTKaidoTYagiSPosttransplant bacteremia in adult living donor liver transplant recipientsLiver Transpl2010161379138521117247
  • KimHKParkYKWangHJEpidemiology and clinical features of post-transplant bloodstream infection: an analysis of 222 consecutive liver transplant recipientsInfect Chemother20134531532424396633
  • BertFLarroqueBPaugam-BurtzCMicrobial epidemiology and outcome of bloodstream infections in liver transplant recipients: an analysis of 259 episodesLiver Transpl20101639340120209598
  • KimYJYoonJHKimSIHigh mortality associated with Acinetobacter species infection in liver transplant patientsTransplant Proc2011432397239921839276
  • OtanEAydinCUstaSAcinetobacter infection in a liver transplantation intensive care unitTransplant Proc201345998100023622607
  • NieKRanRTanWRisk factors of intra-abdominal bacterial infection after liver transplantation in patients with hepatocellular carcinomaChin J Cancer Res20142630931425035658
  • HoranTCAndrusMDudeckMACDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care settingAm J Infect Control20083630933218538699
  • FlorescuDFQiuFLangnasANBloodstream infections during the first year after pediatric intestinal transplantationPediatr Infect Dis J20123170070422466325
  • LevryMMFinkMPMarshallJCfor the International Sepsis Definitions Conference2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definition ConferenceIntensive Care Med20032953053812664219
  • KollefMHMicekSTStrategies to prevent antimicrobial resistance in the intensive care unitCrit Care Med2005331845185316096464
  • WanQYeQZhouJMortality predictors of bloodstream infections in solid-organ transplant recipientsExp Clin Transplant20131121121423190439
  • Clinical and Laboratory Standards InstitutePerformance Standards for Antimicrobial Disk Susceptibility Tests, 16th Informational SupplementCLSI document M100-S16Wayne, PA, USAClinical and Laboratory Standards Institute2006
  • van DeldenCBlumbergEAMultidrug resistant gram-negative bacteria in solid organ transplant recipientsAm J Transplant20099Suppl 4S27S3420070690
  • BodroMSabéNTubauFRisk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipientsTransplantation20139684384923883973
  • LeeHWKohYMKimJCapacity of multidrugresistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfacesClin Microbiol Infect200814495418005176
  • LeeJCKoertenHvan den BroekPAdherence of Acinetobacter baumannii strains to human bronchial epithelial cellsRes Microbiol200615736036616326077
  • ReddyPZembowerTRIsonMGCarbapenem-resistant Acinetobacter baumannii infections after organ transplantationTranspl Infect Dis201012879319735384
  • ShieldsRKClancyCJGillisLMEpidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipientsPLoS One20127e5234923285002
  • NunleyDRBauldoffGSManginoJEMortality associated with Acinetobacter baumannii infections experienced by lung transplant recipientsLung201018838138520607268
  • de GouvêaEFMartinsISHalpernMThe influence of carbapenem resistance on mortality in solid organ transplant recipients with Acinetobacter baumannii infectionBMC Infect Dis20121235123237530
  • ZhongLMenTYLiHMultidrug-resistant gram-negative bacterial infections after liver transplantation – spectrum and risk factorsJ Infect20126429931022198738
  • MartinsNMartinsISde FreitasWVSevere infection in a lung transplant recipient caused by donor-transmitted carbapenem-resistant Acinetobacter baumanniiTranspl Infect Dis20121431632022168176
  • WoodGCHanesSDCroceMAComparison of ampicillin- sulbactam and imipenem-cilastin for the treatment of Acinetobacter ventilator-associated pneumoniaClin Infect Dis2002341425143012015687
  • JellisonTKMcKinnonPSRybakMJEpidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastin or ampicillin-sulbactamPharmacotherapy20012114214811213849
  • TacconeFSRodriguez-VillalobosHDe BackerDSuccessful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecyclineEur J Clin Microbiol Infect Dis20062525726016572310
  • CaiYChaiDWangRColistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategiesJ Antimicrob Chemother2012671607161522441575
  • SunHYShieldsRKCacciarelliTVA novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipientTranspl Infect Dis20101255556020626709
  • KuKPogueJMMoshosJRetrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infectionsAm J Infect Control20124098398722440526
  • ShieldsRKKwakEJPotoskiBAHigh mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimenDiagn Microbiol Infect Dis20117024625221353436
  • MermelLAPrevention of intravascular catheter-related infectionsAnn Intern Med200213239140210691590